Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

17.90

+0.51 (2.93%)

At close: Jun 26, 2026, 4:00 PM EDT

19.81

+1.91 (10.67%)

After-hours: Jun 26, 2026, 7:59 PM EDT

Viridian Therapeutics Employees

Viridian Therapeutics had 252 employees as of December 31, 2025. The number of employees increased by 109 or 76.22% compared to the previous year.

Employees

252

Change (1Y)

109

Growth (1Y)

76.22%

Revenue / Employee

$281,421

Profits / Employee

-$1,203,440

Market Cap

1.98B

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	252	109	76.22%
Dec 31, 2024	143	49	52.13%
Dec 31, 2023	94	8	9.30%
Dec 31, 2022	86	36	72.00%
Dec 31, 2021	50	23	85.19%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Company Name	Employees
Iovance Biotherapeutics	975
Lakefront Biotherapeutics NV	558
Nurix Therapeutics	317
Harmony Biosciences Holdings	293
Kardigan	241
Stoke Therapeutics	170
Precigen	160
Taysha Gene Therapies	99